Daily Archives

November 16, 2019

Novartis Adakveo approved by FDA for Sickle Cell Disease

  • November 16, 2019
  • Burrell Jacqueline

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading



				
Powered by DoJiggy Nonprofit Website Hosting
production42d0